• Users Online: 411
  • Print this page
  • Email this page

   Instructions to Authors

The Editorial Process |  Clinical trial registry Authorship Criteria |  Contribution Details |   Conflicts of Interest/ Competing Interests | Submission of Manuscripts | Preparation of Manuscripts | Copies of any permission(s) | Types of Manuscripts | Protection of Patients' Rights..Sending a revised manuscript | Reprints and proofs | Copyrights  Checklist Contributors' form


The Editorial Process


A manuscript will be reviewed for possible publication with the understanding that it is being submitted to INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU readers are also liable to be rejected at this stage itself.

Manuscripts received from Editorial Board (EB) members: The journal will be following double blind peer review process for all articles. The external peer reviewers selected will not be affiliated with the institution/organization as that of the author(s).  The manuscripts submitted by the Society and EB members are no exceptions. The Society and EB members (including the Editor-in-Chief) are never included in any editorial or review process of their authored submissions and will be excluded from publication decisions. All Society and EB members are expected to mention their association with the journal and declare Conflict of Interest during manuscript submission.

Manuscripts that are found suitable for publication in INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU are sent to two or more expert reviewers. During submission, the contributor is requested to provide names of two or three qualified reviewers who have had experience in the subject of the submitted manuscript, but this is not mandatory. The reviewers should not be affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments in manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point-by-point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript. Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within three days. It may not be possible to incorporate corrections received after that period. The whole process of submission of the manuscript to final decision and sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online as ‘Ahead of Print’ immediately on acceptance.

Processes for appeals

The authors do have the right to appeal if they have a genuine cause to believe that the editorial board has wrongly rejected the paper. If the authors wish to appeal the decision, they should email the editorial office ([email protected]) explaining in detail the reason for the appeal. The appeals will be acknowledged by the editorial office and will be investigated in an unbiased manner. The processing of appeals will be done within 6 – 8 weeks. While under appeal, the said manuscript should not be submitted to other journals. The final decision rests with the Editor in Chief of the journal. Second appeals are not considered.

 Anti-plagiarism policy  


Plagiarism includes duplicate publication of the author’s own work, in whole or in part without proper citation or mispresenting other’s ideas, words, and other creative expression as one’s own. The journal follows strict anti-plagiarism policy. All manuscripts submitted to INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU undergoes plagiarism check through a commercially available software. Based on the extent of plagiarism, authors may be asked to address any minor duplication, or similarity with the previous published work. If plagiarism is detected after publication, the Journal will investigate. If plagiarism is established, the journal will notify the authors’ institution and funding bodies and will retract the plagiarised article. To report plagiarism, contact the journal office at [email protected].

 Clinical trial registry  


INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU favours registration of clinical trials and is a signatory to the Statement on publishing clinical trials in Indian biomedical journals. INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU would publish clinical trials that have been registered with a clinical trial registry that allows free online access to public. Registration in the following trial registers is acceptable:

http://www.ctri.nic.in/https://www.anzctr.org.au/http://www.clinicaltrials.gov/http://isrctn.org/http://www.trialregister.nl/trialreg/index.asphttp://www.umin.ac.jp/ctr.This is applicable to clinical trials that have begun enrolment of subjects in or after June 2018. Clinical trials that have commenced enrolment of subjects prior to June 2018 would be considered for publication in INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU only if they have been registered retrospectively with clinical trial registry that allows unhindered online access to public without charging any fees.

  • Clinical trials (interventional studies) only those are registered with Clinical Trials Registry- India (CTRI) http://www.ctri.nic.in will be considered for publication.
  • The authors need to mention CTRI registration number in covering letter and in the article file.
  • All the randomized controlled trials should be described on the basis of revised CONSORT statement, which is available at http://www.consort-statement.org.


 Authorship Criteria


All those designated as authors/contributors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors.

  1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  2. Drafting the work or revising it critically for important intellectual content; AND
  3. Final approval of the version to be published; AND
  4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content of the manuscript. The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. Once submitted the order cannot be changed without written consent of all the contributors. The journal prescribes a maximum number of authors for manuscripts depending upon the type of manuscript, its scope and number of institutions involved (vide infra). The authors should provide a justification, if the number of authors exceeds these limits.

Author declaration: All authors must declare their contributions to the manuscript and confirm their authorship by uploading a signed Copyright Transfer Form. All authors must also declare their conflict of interest by uploading and INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU Conflict of Interest Form duly filled by each author. Please upload the filled, signed forms (Author Contribution Form) while submitting the manuscript on our online manuscript processing system https://review.jow.medknow.com/ .

Contributors who meet fewer than all 4 of the above criteria for authorship should not be listed as authors, but they should be acknowledged. The corresponding author should obtain written permission to be acknowledged from all acknowledged individuals.

 Contribution Details


Contributors should provide a description of contributions made by each of them towards the manuscript. Description should be divided in following categories, as applicable: concept, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing and manuscript review. Authors' contributions will be printed along with the article. One or more authors should take responsibility for the integrity of the work as a whole from inception to published article and should be designated as 'guarantor’. The authors must fully declare their contributions to the manuscript. A CReDiT (Contributor Roles Taxonomy) Author Statement must be uploaded as part of the Covering Letter.

 Conflicts of Interest/ Competing Interests


All authors of articles must disclose any and all conflicts of interest they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. If the articles are authored by the editorial board, the conflict of interest must be clearly stated. 

All authors are expected to fill the INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU Conflict of Interest form and this form must be uploaded during manuscript submission. The Conflict-of-Interest Form can be found here.

Submission of Manuscripts


All manuscripts must be submitted on-line through the website http://www.journalonweb.com/. First time users will have to register at this site. Registration is free but mandatory. Registered authors can keep track of their articles after logging into the site using their username and password. Authors do not have to pay for submission, processing or publication of articles. If you experience any problems, please contact the editorial office by e-mail at [email protected].

The submitted manuscripts that are not as per the “Instructions to Authors” would be returned to the authors for technical correction before they undergo editorial/ peer-review. Generally, the manuscript should be submitted in the form of two separate files:

[1] Title Page/First Page File/covering letter

This file should provide

  1. The type of manuscript (original article, case report, review article, Letter to editor, Images, etc.) title of the manuscript, running title, names of all authors/ contributors (with their highest academic degrees, designation and affiliations) and name(s) of department(s) and/ or institution(s) to which the work should be credited. All information which can reveal your institute affiliation should be here. Use text/rtf/doc files. Do not zip the files.
  2. The total number of pages, total number of photographs and word counts separately for abstract and for the text (excluding the references, tables and abstract), word counts for introduction + discussion in case of an original article.
  3. If the manuscript was presented as part at a meeting, the organization, place, and exact date on which it was read. A full statement to the editor about all submissions and previous reports that might be regarded as redundant publication of the same or very similar work. Any such work should be referred to specifically and referenced in the new paper. Copies of such material should be included with the submitted paper, to help the editor decide how to handle the matter.
  4. Registration number in case of a clinical trial and where it is registered (name of the registry and its URL).
  5. Source(s) of support in the form of grants, equipment and/or drugs. Manuscripts should include details about the funding agency/ sponsors, grant number and the role of funders. If the funders have no role to play or the study did not receive funding, a statement declaring the same should be mentioned. 
  6. A statement confirming appropriate patient consent for publication has been obtained should be mentioned for case reports/ case series, and articles that include patient images.
  7. Acknowledgement, if any. One or more statements should specify 1) contributions that need acknowledging but do not justify authorship, such as general support by a departmental chair; 2) acknowledgments of technical help; and 3) acknowledgments of financial and material support, which should specify the nature of the support.
  8. Conflicts of Interest of each author/ contributor: All manuscripts for articles, original research reports, editorials, comments, reviews, book reviews, and letters submitted to the journal must include a conflict-of-interest disclosure statement or a declaration by the authors that they do not have any conflicts of interest to declare. A statement of financial or other relationships that might lead to a conflict of interest, if that information is not included in the manuscript itself or in an authors' form.
  9. Data Availability statement: All manuscripts should include a statement about where data supporting the results reported in a published article can be found.
  10. Data sharing statement: Clinical trials must contain a data sharing statement such as whether individual deidentified participant data (including data dictionaries) will be shared (“undecided” is not an acceptable answer); what data in particular will be shared; whether additional, related documents will be available (e.g., study protocol, statistical analysis plan, etc.); when the data will become available and for how long; by what access criteria data will be shared (including with whom, for what types of analyses, and by what mechanism).
  11. Clinical trials articles should include a statement about Where the full trial protocol can be accessed, if available
  12. Criteria for inclusion in the authors’/ contributors’ list (CRediT taxonomy)
  13. A statement that the manuscript has been read and approved by all the authors, that the requirements for authorship as stated earlier in this document have been met, and that each author believes that the manuscript represents honest work, if that information is not provided in another form (see below); and
  14. The name, address, e-mail, and telephone number of the corresponding author, who is responsible for communicating with the other authors about revisions and final approval of the proofs, if that information is not included on the manuscript itself.
  15. If a manuscript is submitted on behalf of a consortium or group, include its name in the manuscript by-line. Do not add it to the author list in the submission system. You may include the full list of members in the Acknowledgments or in a supporting information file.

[2] Blinded Article file: The main text of the article, beginning from Abstract till References (including tables) should be in this file. The file must not contain any mention of the authors' names or initials or the institution at which the study was done or acknowledgements. Page headers/running title can include the title but not the authors' names. Manuscripts not in compliance with the Journal's blinding policy will be returned to the corresponding author. Use rtf/doc files. Do not zip the files. Limit the file size to 1 MB. Do not incorporate images in the file. If file size is large, graphs can be submitted as images separately without incorporating them in the article file to reduce the size of the file. The pages should be numbered consecutively, beginning with the first page of the blinded article file. Hence, the authors must ensure that the main manuscript file does not contain author details or any details that may reveal their identity.

[3] Images: Submit good quality colour images. Each image should be less than 2 MB in size. Size of the image can be reduced by decreasing the actual height and width of the images (keep up to 1600 x 1200 pixels or 5-6 inches). Images can be submitted as jpeg files. Do not zip the files. Legends for the figures/images should be included at the end of the article file. 

[4] The contributors' / copyright transfer form: Contributors’ form / copyright transfer form can be submitted online from the authors’ area on http://www.journalonweb.com/.

Copyright Transfer: All authors must sign the Copyright Transfer Form at the time of manuscript submission as it is a confirmation from all the authors that the copyright is transferred to the journal upon publication. Signature of corresponding author on behalf of all authors is not acceptable.

 Preparation of Manuscripts


Manuscripts must be prepared in accordance with "Uniform requirements for Manuscripts submitted to Biomedical Journals" developed by the International Committee of Medical Journal Editors (Updated December 2021). The uniform requirements and specific requirement of INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU are summarized below. Before submitting a manuscript, contributors are requested to check for the latest instructions available. Instructions are also available from the website of the journal (https://www.ijaim.in/) and from the manuscript submission site http://www.journalonweb.com/).

INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU accepts manuscripts written in British English.

 Copies of any permission(s)


It is the responsibility of authors/ contributors to obtain permissions for reproducing any copyrighted material. A copy of the permission obtained must accompany the manuscript. Copies of any and all published articles or other manuscripts in preparation or submitted elsewhere that are related to the manuscript must also accompany the manuscript.

 Types of Manuscripts


The authors are required to use the downloadable word document templates provided at the end of this page to prepare the manuscripts. The reporting guidelines checklist is provided in these templates which must be duly followed. The authors can also choose the reporting guidelines for the specific study design from the web links provided in the table below and upload it along with the manuscript.

Reporting guidelines: The authors are expected to follow relevant reporting guidelines prescribed by the EQUATOR Network. Please visit to select the appropriate reporting guideline relevant to your study type: https://www.equator-network.org/

Original Research Article (Experimental):

The abstract should be restricted to 250 words (including background, objectives, materials and methods, results and conclusion. The manuscript should be restricted to about 5000 words, around 70 references and 8 non-text items.

Experimental research articles should be on author’s original research and must be more technical or specialized in nature. They may include studies on quality control of herbal drugs, standardization of finished formulations, standardization of Ayurvedic  pharmaceutical procedures, toxicity and efficacy studies and similar research works (other than clinical research). Studies including improvised or newer techniques for standardization of raw drugs or development of advanced methods for diagnosis of diseases based on Ayurvedic classical guidelines are also welcome. Authors should mention details of authentication of raw drugs and finished formulations used, institutional animal ethical committee clearance (wherever applicable) and guidelines followed for the study. Sufficient details should be provided in case of laboratory procedures. If commercial products are used, provide the name and address of the manufacturer. For in-vivo research studies, ARRIVE guidelines should be followed. The guidelines are available at the following link:https://www.nc3rs.org.uk/arrive-guidelines


Original Research Article (Clinical):

Articles on clinical research within the scope of IJAIM are welcome. This may include clinical trials, cross sectional studies, case control studies and cohort studies. Since the research involves human subjects, approval should be obtained by the institutional ethical committee and the reference number should be mentioned wherever applicable. Any information which might reveal the identity of the patient like photographs, sonograms, CT scans or patient descriptions should not be included unless the information is very essential for scientific purposes. Also written consent should be obtained from the patient (or from parent or guardian in case of minor patients) if any details disclosing his/her identity are used in the article. Informed consent should be mentioned in the article. The consent form    for any raw data should be provided to the journal office when asked by the editorial board. Abstract should be structured and should be restricted to 250 words. The manuscript should be restricted to between 3000 to 5000 words excluding about 70 references and 8 non-text items. The manuscript should clearly state the objectives / hypothesis, the study design or materials and methods including inclusion and exclusion criteria, intervention method, outcomes or results, discussion on study outcomes and limitations and the conclusion. It is necessary for the clinical trials to be registered with Clinical trials registry – India (CTRI), kindly refer the link http://www.ctri.nic.in. The CTRI registration number should be  mentioned in the Cover letter and also in the manuscript file. For randomized controlled studies, follow CONSORT guidelines available at http://www.consort-statement.org/. Also mention the details about authentication of raw drugs and formulations used, Institutional Ethical committee clearance certificate, study guidelines followed, and the informed consent obtained from the patients. If commercial products are used, provide the name and address of the manufacturer.

Abstract: Abstract should be concise and factual. It should be structured wherever required. It should briefly state the objectives of the study, principal results, and major conclusions. The abstract should be such that it stands alone and represents the whole article. References and abbreviations must be avoided.

Keywords: A maximum of 6 keywords relevant to the article should be provided after the abstract. Avoid general and plural terms, multiple concepts, and abbreviations in keywords. It is advisable to follow MeSH guidelines for keywords and for the headings in the main article since this is used as standard for indexing and information retrieval purposes. The MeSH guidelines can be downloaded from the web address https://www.nlm.nih.gov/mesh. For technical terminologies of Ayurveda, it is advisable to use the standard nomenclature as mentioned in Ayush portal available at http://ayushportal.nic.in/srchterms.aspx.

Introduction: State the purpose and summarize the rationale for the study or observation. 

Materials and Methods: It should include and describe the following aspects:

Ethics: When reporting studies on human beings, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as amended in 2013 (available at https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). For prospective studies involving human participants, authors are expected to mention about approval of (regional/ national/ institutional or independent Ethics Committee or Review Board, obtaining informed consent from adult research participants and obtaining assent for children aged over 7 years participating in the trial. The age beyond which assent would be required could vary as per regional and/ or national guidelines. Ensure confidentiality of subjects by desisting from mentioning participants’ names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution’s or a national research council’s guide for, or any national law on the care and use of laboratory animals was followed. Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible, and the details of anaesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the CPCSEA and World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Humans for studies involving experimental animals and human beings, respectively). The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the ‘Materials and Methods’ section.

Study design:

Selection and Description of Participants: Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population. Technical information: Identify the methods, apparatus (give the manufacturer's name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration. The details about the methods of sample size calculation should be included.

Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement (http://www.consort-statement.org).

The authors are required to use the downloadable word document templates provided at the end of this page to prepare the manuscripts. The reporting guidelines checklist is provided in these templates which must be duly followed. The authors can also choose the reporting guidelines for the specific study design from the web links provided in the table below and upload it along with the manuscript. Manuscripts with the incomplete checklist will be sent back to the authors.

Reporting Guidelines for Specific Study Designs


Type of Study



Observational studies including cohort, case-control, and cross-sectional studies



Randomized controlled trials



Quality improvement projects



Systematic reviews and meta-analyses



Studies of diagnostic accuracy



Case Reports



Clinical Practice Guidelines


The reporting guidelines for other type of studies can be found at https://www.equator-network.org/reporting-guidelines/.

Statistics: Whenever possible quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Authors should report losses to observation (such as, dropouts from a clinical trial). When data are summarized in the Results section, specify the statistical methods used to analyse them. Avoid non-technical uses of technical terms in statistics, such as 'random' (which implies a randomizing device), 'normal', 'significant', 'correlations', and 'sample'. Define statistical terms, abbreviations, and most symbols. Specify the computer software used. Use upper italics (P 0.048). For all P values include the exact value and not less than 0.05 or 0.001. Mean differences in continuous variables, proportions in categorical variables and relative risks including odds ratios and hazard ratios should be accompanied by their confidence intervals.

Results: Present your results in a logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. Extra- or supplementary materials and technical detail can be placed in an appendix where it will be accessible but will not interrupt the flow of the text; alternatively, it can be published only in the electronic version of the journal.

When data are summarized in the Results section, give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and specify the statistical methods used to analyse them. Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Where scientifically appropriate, analyses of the data by variables such as age and sex should be included.

Discussion: Include summary of key findings (primary outcome measures, secondary outcome measures, results as they relate to a prior hypothesis); Strengths and limitations of the study (study question, study design, data collection, analysis and interpretation); Interpretation and implications in the context of the totality of evidence (is there a systematic review to refer to, if not, could one be reasonably done here and now?, what this study adds to the available evidence, effects on patient care and health policy, possible mechanisms); Controversies raised by this study; and Future research directions (for this particular research collaboration, underlying mechanisms, clinical research). 

Do not repeat in detail data or other material given in the Introduction or the Results section. In particular, contributors should avoid making statements on economic benefits and costs unless their manuscript includes economic data and analyses. Avoid claiming priority and alluding to work that has not been completed. New hypotheses may be stated if needed, however they should be clearly labelled as such. About 70 references can be included. These articles generally should not have more than six authors.

Review Articles:

It is expected that these articles would be written by individuals who have done substantial work on the subject or are considered experts in the field. A short summary of the work done by the contributor(s) in the field of review should accompany the manuscript.

The prescribed word count is 3000 to 6000 words (excluding around 70 references) and about 8 non-text items words excluding tables, references and abstract. The manuscript may have about 70 references. The manuscript should have an unstructured Abstract (250 words) representing an accurate summary of the article. The section titles would depend upon the topic reviewed. Authors submitting review article should include a section describing the methods used for locating, selecting, extracting, and synthesizing data. These methods should also be summarized in the abstract.

The journal expects the contributors to give post-publication updates on the subject of review. The update should be brief, covering the advances in the field after the publication of the article and should be sent as a letter to editor, as and when major development occurs in the field.

The Journal prefers systematic reviews that have been registered in PROSPERO https://www.crd.york.ac.uk/prospero/. The PROSPERO registry number should be provided in the review article under the “methodology” section.

Case reports:

New, interesting and rare cases can be reported. They should be unique, describing a great diagnostic or therapeutic challenge and providing a learning point for the readers. Cases with clinical significance or implications will be given priority. These communications could be of up to 1500 words (excluding Abstract and references) and should have the following headings: Abstract (unstructured), Keywords, Introduction, Case report, Discussion, Reference, Tables and Legends in that order.

The manuscript could be of up to 1500 words (excluding references and abstract) and could be supported with up to 20 references 2 non-texts and include a non-structured abstract of up to 200 words. Kindly follow CARE guidelines available at http://www.care-statement.org for case reports. Patient's identity should not be revealed from the clinical photographs or CT/USG pictures. Case Reports could be authored by up to four authors.


Editorials are written by the members of the Editorial Board or by Guest Editors specially invited by the Editor-in-chief. Manuscript shall be restricted to about 1500 words with around 15 references.


Letter to the Editors:

Letters are welcome from all readers on topics and issues pertaining to articles in recent editions of IJAIM, or to the worlds mainly of Ayurveda and other interdisciplinary branches. Letters should be brief, concise and to the point. Manuscript should be restricted to about 1000 words (excluding around 15 references) and 1 non-text item.

Apart from the above, following article types will be published as e-Publication only.

Conference Report:

Manuscript should be restricted to 1200 words with maximum two non-text items.

News and Events:                                                          

These are written by IJAIM editorial board members or by those who have conducted national / international event in Ayurveda and integrated medicine. Readers may suggest topics and events for publication pertaining recent activities in the field of Ayurveda and Integrative sciences. Requests for particular events to be covered and suggestions on the person to write the event report may be submitted to the editorial board. Please contact the editor at [email protected].


Commentary and Opinion are solicited by the editorial board.

References should be numbered consecutively in the order in which they are first mentioned in the text (not in alphabetic order). Identify references in text, tables, and legends by numerals in superscript with square bracket after the punctuation marks. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure. Use the style of the examples below, which are based on the formats used by the NLM in Index Medicus. The titles of journals should be abbreviated according to the style used in Index Medicus. Use complete name of the journal for non-indexed journals. Avoid using abstracts as references. Information from manuscripts submitted but not accepted should be cited in the text as "unpublished observations" with written permission from the source. Avoid citing a "personal communication" unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text. 
The commonly cited types of references are shown here, for other types of references such as newspaper items please refer to ICMJE Guidelines (http://www.icmje.org or http://www.nlm.nih.gov/bsd/uniform_requirements.html). All references must be uploaded separately and not as part of the main manuscript file.

Examples of references:

  1. Reference from Ayurvedic classical texts - original reference

Eg. Acharya Agnivesha, Charaka Samhita, elaborated by Acharya Charaka and Dridhabala, Varanasi, Chaukhambha Surabharati Prakashan; 2009; 32.

  1. Verse from commentary on classical texts

Eg. Acharya Chakrapani, Ayurveda Dipikavyakhya, on Charaka Samhita of Acharya Charaka,Varanasi, Chaukhambha Surabharati Prakashan; 2009; 138.

  1. Reference from editor’s comments

Eg.Dr.Gangasahay Pandeya, Editor, Bhavaprakasha Nighantu of Acharya Bhavamishra, Varanasi, Chaukhambha Bharati Academy; 2010; 76.

  1. Reference from article in a book

Eg. Lawrence J. A., & Dodds A. E., Goal-directed activities and life-span development. In J. Valsiner& K. Connolly (Editors), Handbook of developmental psychology, London, England: Sage Publications. 2003; 517-533.

  1. Reference from a standard journal article (for up to six authors)

Eg.,Nagalakshmi M.A.H., Thangadurai D., Muralidara D. & Pullaiah R.T. Phytochemical and antimicrobial study of Chukrasiatabularis leaves. Fitoterapia; 2001; 72, 62–64.

  1. Reference from a standard journal article (for more than six authors)

Eg.Bacsal K, Chavez L, Diaz I, Espina S, Javillo J, Manzanilla H et al.,. The Effect of Swietenia Mahogani (Mahogany) Seed Extract On Indomethacin-Induced Gastric Ulcers InFemale Sprague- Dawley Rats. Acta Medica Philippina; 1997; 3, 127–139.

  1. Web references – full URL with the date when it was last accessed should be given. http://www.planetayurveda.com/library/kushta-saussurea-lappa, last accessed on 24-5-2018.
  2. Reference from a supplement issue

Eg. A Ramachandran, AK Das, SR Joshi, CS Yajnik, S Shah, KM Prasanna Kumar, Current Status of Diabetes in India and Need for Novel Therapeutic Agents, Supplement to JAPI; June 2010; volume 58, page 7 to 9.

  1. Regional language books – author and editor

Eg. Dr.G.R.Paranjape, Sanjeevan Chikitsa; Belagavi, Swastik printing press; 1998; 18.

Eg. Vaidya Murli Madhwacharya, Editor, for Divyoushadhi of Dr. Hanamantharao Savanur, Poorvardha, Bagalkot, Ayurveda Sevakuti Prakashana; 1955; 16.


  • Tables should be self-explanatory and should not duplicate textual material.
  • Tables with more than 10 columns and 25 rows are not acceptable.
  • Number tables, in numerals, consecutively in the order of their first citation in the text and supply a brief title for each.
  • Place explanatory matter in footnotes, not in the heading.
  • Explain in footnotes all non-standard abbreviations that are used in each table.
  • Obtain permission for all fully borrowed, adapted, and modified tables and provide a credit line in the footnote.
  • For footnotes use the following symbols, in this sequence: *, †, ‡, §, ||,¶ , **, ††, ‡‡
  • Tables with their legends should be provided at the end of the text after the references. The tables along with their number should be cited at the relevant place in the text

Illustrations (Figures)

  • Upload the images in JPEG format. The file size should be within 1024 kb in size while uploading.
  • Figures should be numbered consecutively according to the order in which they have been first cited in the text.
  • Labels, numbers, and symbols should be clear and of uniform size. The lettering for figures should be large enough to be legible after reduction to fit the width of a printed column.
  • Symbols, arrows, or letters used in photomicrographs should contrast with the background and should be marked neatly with transfer type or by tissue overlay and not by pen.
  • Titles and detailed explanations belong in the legends for illustrations not on the illustrations themselves.
  • When graphs, scatter-grams or histograms are submitted the numerical data on which they are based should also be supplied.
  • The photographs and figures should be trimmed to remove all the unwanted areas.
  • If photographs of individuals are used, their pictures must be accompanied by written permission to use the photograph.
  • If a figure has been published elsewhere, acknowledge the original source and submit written permission from the copyright holder to reproduce the material. A credit line should appear in the legend for such figures.
  • Legends for illustrations: Type or print out legends (maximum 40 words, excluding the credit line) for illustrations using double spacing, with Arabic numerals corresponding to the illustrations. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, identify and explain each one in the legend. Explain the internal scale (magnification) and identify the method of staining in photomicrographs.
  • Final figures for print production: Send sharp, glossy, un-mounted, colour photographic prints, with height of 4 inches and width of 6 inches at the time of submitting the revised manuscript. Print outs of digital photographs are not acceptable. If digital images are the only source of images, ensure that the image has minimum resolution of 300 dpi or 1800 x 1600 pixels in TIFF format. Send the images on a CD. Each figure should have a label pasted (avoid use of liquid gum for pasting) on its back indicating the number of the figure, the running title, top of the figure and the legends of the figure. Do not write the contributor/s' name/s. Do not write on the back of figures, scratch, or mark them by using paper clips.
  • The Journal reserves the right to crop, rotate, reduce, or enlarge the photographs to an acceptable size. 

Appendices: Appendices should be identified as A,B etc. Math formulae and equations should be given separate numbering like Eq A1, Eq A2, Eq B1 etc. For tables and figures, use numbering like Table A1, Figure A1 etc.

List of Abbreviations: Only standard abbreviations are allowed. They should be placed in a footnote on the first page of the article. Consistency of abbreviations should be maintained throughout the article.

Nomenclature and units: Always follow internationally accepted nomenclature and standard units. If other quantities are used, mention their equivalents in SI.

Math formulae: Formulae and equations should be in the form of editable texts and not as images. Keep the equations simple. Eg., use solidus (/) instead of a horizontal line for fractions, to denote power use superscript etc.

Acknowledgements: For non-author contributions, one or more statements should specify 1) contributions that need acknowledging but do not justify authorship, such as general support by a departmental chair; 2) acknowledgments of technical help; and 3) acknowledgments of financial and material support, which should specify the nature of the support. Details of the non-author contributors can be cited individually or collectively, and their precise contributions should be specified. The corresponding author is required to obtain written permission to be acknowledged from all acknowledged individuals.

Financial disclosure: Manuscripts should include details about the funding agency/ sponsors, grant number and the role of funders. If the funders have no role to play or the study did not receive funding, a statement declaring the same should be mentioned. 

Conflict of interest: All manuscripts for articles, original research reports, editorials, comments, reviews, book reviews, and letters submitted to the journal must include a conflict-of-interest disclosure statement or a declaration by the authors that they do not have any conflicts of interest to declare. If the articles are authored by the editorial board, the conflict of interest must be clearly stated.

Data Availability statement: All manuscripts should include a statement about where data supporting the results reported in a published article can be found or the authors’ willingness to share the data on request.

Copies of any permissions: If excerpts from other copyrighted works are included, the author must obtain written permission from the copyright owners and credit the sources in the article. A copy of the permission obtained should be uploaded along with the manuscript.

Additional instructions:

  • All Sanskrit words should be written in roman transliteration with the diacritical marks. Devanagari script is not allowed.
  • All Sanskrit terms should be translated, and the original term and the translation should be mentioned together. The translation should be in parenthesis at the first mention of the term in the article or hyperlinking can be done.
  • References from classical texts of Ayurveda should be mentioned with the original passage/verse and translation as the footnote.
  • Sanskrit terms should be avoided where non-controversial English equivalents are available. Eg. Ghee for ghrita.

Protection of Patients' Rights to Privacy 


Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian, wherever applicable) gives informed consent for publication. Authors should remove patients' names from figures even if they have obtained informed consent from the patients in order to protect patient privacy. The journal abides by ICMJE guidelines:

  1. Authors, not the journals nor the publisher, need to obtain the patient consent form before the publication and have the form properly archived. The consent forms are not to be uploaded with the cover letter or sent through email to editorial or publisher offices.
  2. If the manuscript contains patient images that preclude anonymity, or a description that has obvious indication to the identity of the patient, a statement about obtaining informed patient consent should be indicated in the manuscript.
  3. In order to protect the patient’s identity, the recognizable facial features not related to the study should be digitally blurred
  4. Written informed consent is the preferred method for obtaining consent. If verbal consent is obtained, the authors must ensure that the verbal consent is recorded in the medical case record of the patient and duly signed by witness. 

 Sending a revised manuscript 


The revised version of the manuscript should be submitted online in a manner similar to that used for submission of the manuscript for the first time. However, there is no need to submit the “First Page” or “Covering Letter” file while submitting a revised version. When submitting a revised manuscript, contributors are requested to include, the ‘referees’ remarks along with point-to-point clarification at the beginning in the revised file itself. In addition, they are expected to mark the changes as underlined or coloured text in the article.

Off prints


As soon as the manuscript is published, the author will be notified and a link to the published version of the open access article on IJAIM will be sent. This link can be shared via email and social networks. The article can be downloaded from this link. One print version also will be sent to the author.

For author enquiries, to check the status of submitted article or to find out when the accepted article will be published, visit the journal website www.ijaim.in

 Resubmission of the article


IJAIM aims at publishing high quality research articles. If any article is found to be of insufficient quality, it will be reviewed by two or more experts in the field and the report will be sent to the author. If the article is substandard, it will be rejected outright, and the decision of the Editorial committee will be final in this regard. Resubmission of such articles can be done as fresh manuscript submission after the suitable revisions.

Reprints and proofs 


Journal provides no free printed reprints. Authors can purchase reprints, payment for which should be done at the time of submitting the proofs.

Publication schedule


The journal publishes articles on its website with a biannual frequency.

Manuscript submission, processing and publication charges   


Journal doesn’t charge the author or the author’s institution for submission, processing or publication of the manuscript. However, the journal shall not provide free reprints. The published manuscript can be downloaded from the journal website. Print version can be obtained from the editorial office by paying the fee of Rs. 1200/-.



The entire contents of the INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU are protected under Indian and international copyrights. The Journal, however, grants to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The journal also grants the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 4.0 International Public License.



Covering letter

  • Signed by all contributors
  • Previous publication / presentations mentioned
  • Source of funding mentioned
  • Conflicts of interest disclosed


  • Last name and given name provided along with Middle name initials (where applicable)
  • Author for correspondence, with e-mail address provided
  • Number of contributors restricted as per the instructions
  • Identity not revealed in paper except title page (e.g. name of the institute in Methods, citing previous study as 'our study', names on figure labels, name of institute in photographs, etc.)

Presentation and format

  • Double spacing
  • Margins 2.5 cm from all four sides
  • Page numbers included at bottom
  • Title page contains all the desired information
  • Running title provided (not more than 50 characters)
  • Abstract page contains the full title of the manuscript
  • Abstract provided (structured abstract of 250 words for original articles, unstructured abstracts of 250 words for review articles and unstructured abstracts of about 150 words for all other manuscripts excluding letters to the Editor)
  • Introduction of 75-100 words
  • Headings in title case (not ALL CAPITALS)
  • The references cited in the text should be after punctuation marks, in superscript with square bracket.
  • References according to the journal's instructions, punctuation marks checked
  • Send the article file without ‘Track Changes’

Language and grammar

  • British English
  • Write the full term for each abbreviation at its first use in the title, abstract, keywords and text separately unless it is a standard unit of measure. Numerals from 1 to 10 spelt out
  • Numerals at the beginning of the sentence spelt out
  • Check the manuscript for spelling, grammar and punctuation errors
  • If a brand name is cited, supply the manufacturer's name and address (city and state/country).
  • Species names should be in italics

Tables and figures

  • No repetition of data in tables and graphs and in text
  • Actual numbers from which graphs drawn, provided
  • Figures necessary and of good quality (colour)
  • Table and figure numbers in Arabic letters (not Roman)
  • Labels pasted on back of the photographs (no names written)
  • Figure legends provided (not more than 40 words)
  • Patients' privacy maintained (if not permission taken)
  • Credit notes for borrowed figures/tables provided
  • Write the full term for each abbreviation used in the table as a footnote

Contributors' form 

Download Template for COI Form. (.DOT file)




What's New